The role of CD4+T cells in SLE has been relatively well characterized: they produce excessive interleukin (IL)‐17, infiltrate tissues, and help B cells generate autoimmune antibodies to trigger autoimmune injury of tissues. This evidence concerns the gene IL17A and systemic lupus erythematosus.